Screening, treatment, and control of hypertension in US private physician offices, 2003-2004
about
Pharmacometabolomics reveals racial differences in response to atenolol treatmentCholesterol treatment with statins: who is left out and who makes it to goal?Screening strategies for cardiovascular disease in asymptomatic adults.Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.Antihypertensive medication adherence, ambulatory visits, and risk of stroke and deathExforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact.Quality of US primary care delivered by resident and staff physicians.Pharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study.Advancing management of hypertension through pharmacogenomicsPharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studyWill hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients?Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.Predicting changes in hypertension control using electronic health records from a chronic disease management programReview article: eplerenone: an underused medication?Genetic discoveries in hypertension: steps on the road to therapeutic translation.The role of direct renin inhibitors in the treatment of the hypertensive diabetic patient.Disparities in Hypertension Associated with Limited English Proficiency.Role of Kidneys in Sex Differences in Angiotensin II-Induced Hypertension.Instrumental variable methods to assess quality of care the marginal effects of process-of-care on blood pressure change and treatment costs.Routine Screening for High Blood Pressure Outside of Primary Care: An Idea Whose Time Has Come.
P2860
Q21559685-C809FF3B-13CC-46C3-9095-6A4C99FD811CQ33541739-DFE83DD0-07F1-455F-86A9-4F058E780F73Q33704011-20545661-C9A5-462A-8C2E-B26231E43C41Q33783232-283FD4D2-A792-45F9-B708-B16FF3690028Q33848968-EB81F4DD-EFAD-43B6-B9B3-2681B8D3D90CQ33973864-DD3C6519-4D66-45B5-8D3C-9DC8CEBD6194Q34164308-B7D36F65-9F54-4B30-81A8-55D62E15054FQ34307609-A925F11F-6219-4B5C-9EEF-95553D747231Q36939501-77484584-F1F9-4E3F-8295-0AFF96716F9FQ37164285-C1241592-2842-45F6-82D1-A9365395B183Q37345400-B93B7DF2-8FB6-46A8-9ABE-2BD7C3348D85Q37421608-1C995500-8D28-4600-B6D6-4B6EC03AB4B0Q37598954-F7F6004E-AC4B-4655-B9C8-2E88BE039DB7Q37793666-9F8D7DD0-18EA-4702-AEBD-846E02EE7781Q38087825-79857C65-61CE-427E-A78F-8E3A28427C42Q38154260-F892A7CF-7355-412B-B570-935CDF1442E0Q38979710-9A1739A2-FA02-4AF5-9803-5D4F4BD2B76AQ47601427-CBF4FA0C-DD4E-433E-95CF-579A3C589E1FQ49748457-760A6154-1BDB-4CC1-A5D2-2A8CEE588339Q53578442-05181C85-569E-4594-8356-5C00973A6513
P2860
Screening, treatment, and control of hypertension in US private physician offices, 2003-2004
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Screening, treatment, and cont ...... e physician offices, 2003-2004
@en
Screening, treatment, and cont ...... physician offices, 2003-2004.
@nl
type
label
Screening, treatment, and cont ...... e physician offices, 2003-2004
@en
Screening, treatment, and cont ...... physician offices, 2003-2004.
@nl
prefLabel
Screening, treatment, and cont ...... e physician offices, 2003-2004
@en
Screening, treatment, and cont ...... physician offices, 2003-2004.
@nl
P2860
P1433
P1476
Screening, treatment, and cont ...... e physician offices, 2003-2004
@en
P2093
Randall S Stafford
P2860
P304
P356
10.1161/HYPERTENSIONAHA.107.107086
P407
P577
2008-03-17T00:00:00Z